Nina Gunnarsson

Nina Gunnarsson is an experienced professional in the biotechnology and biopharmaceutical sectors, currently serving as the New Product Introduction Director at Ascendis Pharma, focusing on early-stage biologics development and upstream processes. Prior roles include consultancy at G-Bio Aps, where support for CRO/CDMO selection and CMC project management were key responsibilities, and director at Novo Nordisk, overseeing strain development and recombinant processes. Nina has also held senior scientific roles at Terranol A/S and Fluxome A/S, managing research projects and optimizing fermentation processes. Educational background includes a PhD in Biotechnology from the Technical University of Denmark and an MSc in Chemical Engineering from Lund University.